1
Cpx (4 each), and clades A, F, CRF01_AE and CRF36_cpx (2 each). In addition, 22 of the studied viruses apparently had nef and gag genes from viruses belonging to different clades, with the majority (8/10) having either a nef or gag gene derived from CRF02_AG. Interestingly, five gag sequences (10 ) and three (5 ) nef sequences were neither obviously recombinant nor easily classifiable into any
1
Tential impact of HIV-1 diversity on both vaccine development and the sustainability of antiretroviral therapies, it is particularly important that molecular epidemiological surveillance is continued in HIV diversity hotspots such as Cameroon. In this study we have focused on characterizing the diversity of gag and nef genes of Cameroonian HIV-1 isolates. These genes are?2013 Tongo et al.; license
1
Ormation were obtained. RNA was extracted from plasma samples, reverse transcribed and PCR amplified as described previously [12] using subtype non-specific HIV-1 primers for HIV-1 full length gag [12] and nef [13] genes, and sequenced. Sequenced fragments were assembled using ChromasPro. Full length gag and nef sequences were generated and aligned using MUSCLE with manual editing in MEGA5, togeth
1
Hway begins with the formation of an antibody C1q complex on the surface of a pathogen or pathogen infected cell. This complex, in turn, activates C2 via serine proteases and is itself also a serine protease[49]. The protein C2a combines with newly cleaved protein C4a to generate a C3 convertase, C2aC4b. C3b forms the central protein complex of the complement system either by binding to complement
1
Ologyj.com/content/10/1/Page 2 ofparticularly relevant because they encode highly immunogenic proteins that are frequently included in candidate vaccines [9-11]. We sequenced 50 full length HIV-1 gag and 55 nef genes from 59 HIV-infected blood donors in Cameroon. To obtain a phylogenetic view of Cameroonian HIV diversity that explicitly accounted for the confounding effects of recombination, we pe
1
Cias Zembe1, Eitel Mpoudi-Ngole2, Carolyn Williamson1,4 and Wendy A Burgers1*AbstractBackground: Cameroon, in west central Africa, has an extraordinary degree of HIV diversity, presenting a major challenge for the development of an effective HIV vaccine. Given the continuing need to closely monitor the emergence of new HIV variants in the country, we analyzed HIV-1 genetic diversity in 59 plasma s
1
Trees were constructed from these sequences with 100 full maximum likelihood bootstrap replicates (implemented in PHYML [14]), following either complete removal of recombinant sequence fragments or the division of recombinant sequences into their constituent fragments by a blinded fully exploratory screen for recombination using RDP3 [15]. The recombination screen was fully exploratory in that eve
1
Equences previously identified as belonging to these known clades by constructing maximum likelihood trees from all available gag and nef sequences for each clade, and selecting one sequence from each of the up to ten most basal lineages from the root of these clades. Anonymously-donated HIV-infected blood units were collected between December 2006 and August 2007 from Yaound?Central Hospital, Cam